![Overview and clarification of the current HR+ HER2- EBC treatment landscape – SPCC](https://oncodaily.com/pub/uploads/2024/12/IMG_4993.jpeg)
SPCC/LinkedIn
Dec 9, 2024, 14:13
Overview and clarification of the current HR+ HER2- EBC treatment landscape – SPCC
SPCC shared on LinkedIn:
“With advancements in medical science, the landscape of breast cancer treatment is constantly evolving. How can we ensure the most effective approach for each patient?
Now available on-demand, our webinar offers a comprehensive overview of current treatment options. It features expert insights into the enhancement and personalisation of adjuvant endocrine therapy, as well as the de-escalation/escalation of surgery, radiotherapy, and adjuvant treatments.
Discussant: FIORITA POULAKAKI;
Experts: Michael Gnant, Stephen Johnston
This webinar is supported by an unrestricted educational grant from Eli Lilly.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 20, 2025, 20:33
Jan 20, 2025, 20:31
Jan 20, 2025, 20:26
Jan 20, 2025, 20:21
Jan 20, 2025, 20:12
Jan 20, 2025, 20:10
Jan 20, 2025, 20:08
Jan 20, 2025, 20:06
Jan 20, 2025, 20:03